Octopus Biosafety SA (FR:MLOCT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Octopus Biosafety SA has announced the resumption of its listing on Euronext Access Paris, effective December 16, 2024, following a commercial court’s decision to extend the observation period until May 2025. The company’s shares had been previously suspended due to a potential asset sale amid liquidation concerns.
For further insights into FR:MLOCT stock, check out TipRanks’ Stock Analysis page.